Biocon Biologics
Dr. Surendra Raju has a vast experience in clinical development and medical affairs, with a background in project management of Phase 3 clinical trials in India and Middle East countries. With a degree in Dentistry and a specialization in Clinical Research, Dr. Raju has held various roles in renowned organizations such as Biocon Biologics, PAREXEL, ICON plc, and Quintiles.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics